Swollen knee is a common syndrome mostly found in geriatric adults. It occurs as a result of accumulation of excess fluid around the knee joint. Causes for occurrence vary from trauma to accidents leading to injuries such as torn ligaments, cartilage tear, and broken bones to some other underlying disease, including rheumatoid arthritis, gout, and tumors. Knee swelling leads to severe joint pains, which may require immediate medication. In addition, the syndrome may lead to stiffness, thus making it difficult for the patient to bend the knee properly. Other complications associated with knee swelling include severe muscle loss and baker’s cyst in some cases. Baker’s cyst is formed due to buildup of excess fluid and requires removal through a surgery known as cyst aspiration. Treatment mechanism includes medications and surgeries. In some serious cases, knee replacement has to be carried out, which involves total cutting away of the bone or cartilage that is involved and replacing it with artificial prosthetics.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global swollen knee treatment market.
Top Impacting Factors
- Rising geriatric population around the globe and subsequent rise in incidents of ageing syndromes such as obesity, arthritis, diabetes, and sports related accidents is anticipated to lead to market growth for swollen knee treatment market.
- Rising awareness about new age technological advancements such as minimal invasive therapeutics in developed regions such as North America and Europe is further anticipated to drive market growth.
- Global financial slowdown coupled with complete shift of healthcare infrastructure toward battling COVID-19 and related effects has resulted in delays in product launches and cancellations with respect to clinical trials. This is bound to hamper market growth of knee replacement market.
- Growing shift towards adoption of non-surgical healthcare mechanisms such as therapeutic procedures, propaedeutic procedures coupled with growing awareness of the side effects and complications associated with surgical replacements may hamper market growth of knee replacement treatment mechanisms.
Key Market Trends
- North America is anticipated to dominate the knee replacement treatment market owing to rising geriatric population in the region coupled with robust healthcare infrastructure, rising awareness among general populace, and effluent purchasing parity to spend on advanced therapeutics.
- In Africa and Middle East, the market is still anticipated to witness slow growth owing to inefficient healthcare infrastructure, lack of technical pharmaceutical knowledge, undeveloped medical facilities, and less awareness on advanced therapeutics.
- “Cooled radio frequency ablation” is a new treatment approved recently by Food and Drug Administration (FDA) for launch in the U.S. market. The treatment makes use of radio signals to target nerves that are responsible for sending pain signals to brain. The treatment has reported pain reduction for about 12 months as per knee regeneration.
- In October 2019, Kitov Pharma Ltd. collaborated with Coeptis Pharmaceuticals for effective channel management of Consensi in the U.S.
Key Benefits of the Report
- This study presents the analytical depiction of the global swollen knee treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global swollen knee treatment market share.
- The current market is quantitatively analyzed to highlight the global swollen knee treatment growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Global Swollen Knee Treatment Report
- Which are the leading players active in the global swollen knee treatment market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the global swollen knee treatment market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is global swollen knee treatment?
- What is the global swollen knee treatment market prediction in the future?
- What are the current trends and predicted trends?
Key Market Segments
- By Type
- Medications
- Patient-controlled Analgesia Pumps
- Nerve Blocks
- Liposomal Bupivacaine
- Surgery
- By Medications
- Opioids
- Corticosteroids
- Others
- By Surgery
- Arthrocentesis
- Arthroscopy
- Knee Replacement
- Total Knee Replacement
- Unicompartmental Knee Replacement
- Others
- By End User
- Hospitals
- Designated Clinics
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Wright Medical Group Inc.
- Fresenius Kabi
- Merck & Co.
- AngioDynamics
- Biomet Inc.
- DePuy Companies Inc.
- Pfizer Inc.
- Exactech
- Stryker Corporation
- Zimmer Holdings
- B. Braun Melsungen AG
- C.R.Bard,
- Smiths Medical
- Teleflex
- Smith & Nephew Plc.